1
|
Silva TC, Eppink M, Ottens M. Digital twin in high throughput chromatographic process development for monoclonal antibodies. J Chromatogr A 2024; 1717:464672. [PMID: 38350166 DOI: 10.1016/j.chroma.2024.464672] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2023] [Revised: 01/14/2024] [Accepted: 01/21/2024] [Indexed: 02/15/2024]
Abstract
The monoclonal antibody (mAb) industry is becoming increasingly digitalized. Digital twins are becoming increasingly important to test or validate processes before manufacturing. High-Throughput Process Development (HTPD) has been progressively used as a tool for process development and innovation. The combination of High-Throughput Screening with fast computational methods allows to study processes in-silico in a fast and efficient manner. This paper presents a hybrid approach for HTPD where equal importance is given to experimental, computational and decision-making stages. Equilibrium adsorption isotherms of 13 protein A and 16 Cation-Exchange resins were determined with pure mAb. The influence of other components in the clarified cell culture supernatant (harvest) has been under-investigated. This work contributes with a methodology for the study of equilibrium adsorption of mAb in harvest to different protein A resins and compares the adsorption behavior with the pure sample experiments. Column chromatography was modelled using a Lumped Kinetic Model, with an overall mass transfer coefficient parameter (kov). The screening results showed that the harvest solution had virtually no influence on the adsorption behavior of mAb to the different protein A resins tested. kov was found to have a linear correlation with the sample feed concentration, which is in line with mass transfer theory. The hybrid approach for HTPD presented highlights the roles of the computational, experimental, and decision-making stages in process development, and how it can be implemented to develop a chromatographic process. The proposed white-box digital twin helps to accelerate chromatographic process development.
Collapse
Affiliation(s)
- Tiago Castanheira Silva
- Department of Biotechnology, Delft University of Technology, van der Maasweg 9, Delft, 2629 HZ, the Netherlands
| | - Michel Eppink
- Downstream Processing, Byondis B.V., Microweg 22, 6503 GB, Nijmegen, the Netherlands; Bioprocessing Engineering, Wageningen University, Droevendaalse steeg 1, 6708 PB, Wageningen, the Netherlands
| | - Marcel Ottens
- Department of Biotechnology, Delft University of Technology, van der Maasweg 9, Delft, 2629 HZ, the Netherlands.
| |
Collapse
|
2
|
Wang FAS, Fan Y, Chung WK, Dutta A, Fiedler E, Haupts U, Peyser J, Kuriyel R. Evaluation of mild pH elution protein A resins for antibodies and Fc-fusion proteins. J Chromatogr A 2024; 1713:464523. [PMID: 38041974 DOI: 10.1016/j.chroma.2023.464523] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2023] [Revised: 11/06/2023] [Accepted: 11/18/2023] [Indexed: 12/04/2023]
Abstract
Protein A affinity chromatography is widely used as a capture step for monoclonal antibodies (mAb) and molecules that possess an Fc-domain, such as fusion proteins and bispecific antibodies. However, the use of low pH (3.0-4.0) to elute the molecule and achieve acceptable yield (>85 %) can lead to product degradation (e.g. fragmentation, aggregation) for molecules sensitive to low pH. In this paper, we describe a comprehensive evaluation of two protein A resins with ligands designed to elute at a milder pH as a result of modified sequences in their Fc and VH3 binding regions. One of the evaluated resins has been made commercially available by Purolite and named Praesto Jetted A50 HipH. Results demonstrated that Jetted A50 HipH could elute the Fc-fusion protein and most mAbs evaluated with an elution pH at or above 4.6. Elution and wash optimization determined run conditions for high recovery (>90 % monomer yield), reduction of high molecular weight (HMW) species (>50 %), and significant host cell protein (HCP) clearance at the mildest elution pH possible. For a pH-stable mAb and a pH-sensitive fusion protein, cell culture material was purified with optimized conditions and demonstrated the mild elution pH resins' ability to purify product with acceptable yield, comparable or better impurity clearance, and significantly milder native eluate pH compared to traditional resins. The benefits of the mild elution pH resins were clearly exemplified for the pH-sensitive protein, where a milder elution buffer and native eluate pH resulted in only 2 % HMW in the eluate that remained stable over 48 h. In contrast, a traditional protein A resin requiring low pH elution led to eluate HMW levels of 8 %, which increased to 16 % over the same hold time. Additionally, these resins have high dynamic binding capacity and allow the use of traditional HCP washes. Therefore, Jetted A50 HipH is an ideal candidate for a platform protein A resin and provides flexibility for pH-sensitive proteins and stable mAbs, while preserving product quality, recovery, and seamless integration into a downstream process.
Collapse
Affiliation(s)
| | - Yamin Fan
- Process Biochemistry, Biogen, Cambridge, MA 02142, USA
| | | | - Amit Dutta
- Research and Development, Repligen Corporation, Waltham, MA 02453, USA
| | | | | | - Jamie Peyser
- Research and Development, Repligen Corporation, Waltham, MA 02453, USA
| | - Ralf Kuriyel
- Research and Development, Repligen Corporation, Waltham, MA 02453, USA
| |
Collapse
|
3
|
Tatli O, Oz Y, Dingiloglu B, Yalcinkaya D, Basturk E, Korkmaz M, Akbulut L, Hatipoglu D, Kirmacoglu C, Akgun B, Turk K, Pinar O, Sariyar Akbulut B, Atabay Z, Tahir Turanli E, Kazan D, Dinler Doganay G. A two-step purification platform for efficient removal of Fab-related impurities: A case study for Ranibizumab. Heliyon 2023; 9:e21001. [PMID: 38027967 PMCID: PMC10651443 DOI: 10.1016/j.heliyon.2023.e21001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2023] [Revised: 09/25/2023] [Accepted: 10/12/2023] [Indexed: 12/01/2023] Open
Abstract
Antibodies (mAbs) and antibody fragments (Fabs) constitute one of the largest and most rapidly expanding groups of protein pharmaceuticals. In particular, antibody fragments have certain advantages over mAbs in some therapeutic settings. However, due to their greater chemical diversity, they are more challenging to purify for large-scale production using a standard purification platform. Besides, the removal of Fab-related byproducts poses a difficult purification challenge. Alternative Fab purification platforms could expedite their commercialization and reduce the cost and time invested. Accordingly, we employed a strong cation exchanger using a pH-based, highly linear gradient elution mode following Protein L affinity purification and developed a robust two-step purification platform for an antibody fragment. The optimized pH gradient elution conditions were determined on the basis of purity level, yield, and the abundance of Fab-related impurities, particularly free light chain. The purified Fab molecule Ranibizumab possessed a high degree of similarity to its originator Lucentis. The developed purification platform highly intensified the process and provided successful clearance of formulated Fab- and process-related impurities (∼98 %) with an overall process recovery of 50 % and, thus, might be a new option for Fab purification for both academic and industrial purposes.
Collapse
Affiliation(s)
- Ozge Tatli
- Molecular Biology-Genetics and Biotechnology, Graduate School, Istanbul Technical University, Turkey
| | - Yagmur Oz
- Molecular Biology-Genetics and Biotechnology, Graduate School, Istanbul Technical University, Turkey
| | - Baran Dingiloglu
- Molecular Biology-Genetics and Biotechnology, Graduate School, Istanbul Technical University, Turkey
| | - Duygu Yalcinkaya
- Molecular Biology-Genetics and Biotechnology, Graduate School, Istanbul Technical University, Turkey
| | - Ezgi Basturk
- Molecular Biology-Genetics and Biotechnology, Graduate School, Istanbul Technical University, Turkey
| | - Melis Korkmaz
- Molecular Biology-Genetics and Biotechnology, Graduate School, Istanbul Technical University, Turkey
| | - Latif Akbulut
- Molecular Biology-Genetics and Biotechnology, Graduate School, Istanbul Technical University, Turkey
| | - Derya Hatipoglu
- Molecular Biology-Genetics and Biotechnology, Graduate School, Istanbul Technical University, Turkey
| | - Cansin Kirmacoglu
- Molecular Biology-Genetics and Biotechnology, Graduate School, Istanbul Technical University, Turkey
| | - Buse Akgun
- Molecular Biology-Genetics and Biotechnology, Graduate School, Istanbul Technical University, Turkey
| | - Kubra Turk
- Molecular Biology-Genetics and Biotechnology, Graduate School, Istanbul Technical University, Turkey
| | - Orkun Pinar
- Department of Bioengineering, Faculty of Engineering, Marmara University, Turkey
| | | | | | - Eda Tahir Turanli
- Molecular Biology-Genetics and Biotechnology, Graduate School, Istanbul Technical University, Turkey
| | - Dilek Kazan
- Department of Bioengineering, Faculty of Engineering, Marmara University, Turkey
| | - Gizem Dinler Doganay
- Molecular Biology-Genetics and Biotechnology, Graduate School, Istanbul Technical University, Turkey
- Department of Molecular Biology and Genetics, Faculty of Arts and Science, Istanbul Technical University, Turkey
| |
Collapse
|
4
|
Li Y. Viral removal by column chromatography in downstream processing of monoclonal antibodies. Protein Expr Purif 2022; 198:106131. [PMID: 35700957 DOI: 10.1016/j.pep.2022.106131] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2022] [Accepted: 06/09/2022] [Indexed: 10/18/2022]
Abstract
For monoclonal antibodies (mAbs) produced in mammalian cells, viral safety is a critical concern. The downstream process, in addition to removing other impurities, needs to ensure robust clearance (removal or inactivation) of potential endogenous and adventitious viruses. In general, Protein A and polishing chromatography steps all can provide certain level of virus removal. Chromatographic removal combined with virus inactivation and nanofiltration usually provides adequate virus clearance across the overall downstream process. This article reviews the virus clearance capability of commonly used column chromatography, with attention to possible interference of virus-mAb interaction on virus removal. In addition, the potential of using viral surrogate as a safe alternative to live virus for assessing viral clearance is briefly discussed.
Collapse
Affiliation(s)
- Yifeng Li
- Technology and Process Development (TPD), WuXi Biologics, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, 200131, China.
| |
Collapse
|
5
|
Iminodiacetic Acid (IDA) Cation-Exchange Nonwoven Membranes for Efficient Capture of Antibodies and Antibody Fragments. MEMBRANES 2021; 11:membranes11070530. [PMID: 34357180 PMCID: PMC8305546 DOI: 10.3390/membranes11070530] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/17/2021] [Revised: 07/08/2021] [Accepted: 07/11/2021] [Indexed: 11/30/2022]
Abstract
There is strong need to reduce the manufacturing costs and increase the downstream purification efficiency of high-value therapeutic monoclonal antibodies (mAbs). This paper explores the performance of a weak cation-exchange membrane based on the coupling of IDA to poly(butylene terephthalate) (PBT) nonwoven fabrics. Uniform and conformal layers of poly(glycidyl methacrylate) (GMA) were first grafted to the surface of the nonwovens. Then IDA was coupled to the polyGMA layers under optimized conditions, resulting in membranes with very high permeability and binding capacity. This resulted in IgG dynamic binding capacities at very short residence times (0.1–2.0 min) that are much higher than those achieved by the best cation-exchange resins. Similar results were obtained in the purification of a single-chain (scFv) antibody fragment. As is customary with membrane systems, the dynamic binding capacities did not change significantly over a wide range of residence times. Finally, the excellent separation efficiency and potential reusability of the membrane were confirmed by five consecutive cycles of mAb capture from its cell culture harvest. The present work provides significant evidence that this weak cation-exchange nonwoven fabric platform might be a suitable alternative to packed resin chromatography for low-cost, higher productivity manufacturing of therapeutic mAbs and antibody fragments.
Collapse
|
6
|
Zhang L, Jiang C, Chen X, Gu J, Song Q, Zhong H, Xiong S, Dong Q, Yu J, Deng N. Large-scale production, purification, and function of a tumor multi-epitope vaccine: Peptibody with bFGF/VEGFA. Eng Life Sci 2020; 20:422-436. [PMID: 32944017 PMCID: PMC7481771 DOI: 10.1002/elsc.202000020] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2020] [Revised: 07/24/2020] [Accepted: 07/02/2020] [Indexed: 12/23/2022] Open
Abstract
In tumor tissue, basic fibroblast growth factor (bFGF) and vascular endothelial growth factor A (VEGFA) promote tumorigenesis by activating angiogenesis, but targeting single factor may produce drug resistance and compensatory angiogenesis. The Peptibody with bFGF/VEGFA was designed to simultaneously blockade these two factors. We were aiming to produce this Fc fusion protein in a large scale. The biological characterizations of Peptibody strains were identified as Escherichia coli and the fermentation mode was optimized in the shake flasks and 10-L bioreactor. The fermentation was scaled up to 100 L, with wet cell weight (WCW) 126 g/L, production 1.41 g/L, and productivity 0.35 g/(L·h) of IPTG induction. The target protein was isolated by cation-exchange, hydrophobic and Protein A chromatography, with total recovery of 60.28% and HPLC purity of 86.71%. The host cells protein, DNA, and endotoxin residues were within the threshold. In mouse model, immunization of Peptibody vaccine could significantly suppressed the tumor growth and angiogenesis, with inhibition rate of 57.73 and 39.34%. The Peptibody vaccine could elicit high-titer anti-bFGF and anti-VEGFA antibodies, which inhibited the proliferation and migration of Lewis lung cancer cell cells by decreasing the Akt/MAPK signal pathways. Therefore, the Peptibody with bFGF/VEGFA might be used as a therapeutic tumor vaccine. The large-scale process we developed could support its industrial production and pre-clinical study in the future.
Collapse
Affiliation(s)
- Ligang Zhang
- Guangdong Province Engineering Research Center for Antibody Drug and ImmunoassayDepartment of BiologyJinan UniversityGuangzhouP. R. China
| | - Chengcheng Jiang
- Guangdong Province Engineering Research Center for Antibody Drug and ImmunoassayDepartment of BiologyJinan UniversityGuangzhouP. R. China
| | - Xi Chen
- Guangdong Province Engineering Research Center for Antibody Drug and ImmunoassayDepartment of BiologyJinan UniversityGuangzhouP. R. China
| | - Jiangtao Gu
- Guangdong Province Engineering Research Center for Antibody Drug and ImmunoassayDepartment of BiologyJinan UniversityGuangzhouP. R. China
| | - Qifang Song
- Guangdong Province Engineering Research Center for Antibody Drug and ImmunoassayDepartment of BiologyJinan UniversityGuangzhouP. R. China
| | - Hui Zhong
- The Biomedicine Translational Institute in Jinan UniversityGuangzhouP. R. China
| | - Sheng Xiong
- Guangdong Jida Genetic Medicine Engineering Research Center Co. LtdGuangzhouP. R. China
| | | | - Jin‐Chen Yu
- Bio‐Thera Solution Co. LtdGuangzhouP. R. China
| | - Ning Deng
- Guangdong Province Engineering Research Center for Antibody Drug and ImmunoassayDepartment of BiologyJinan UniversityGuangzhouP. R. China
| |
Collapse
|
7
|
Li Y, Chang A, Beattie D, Remington KM. Novel spiking methods developed for anion exchange chromatography operating in a continuous process. Biotechnol Bioeng 2020; 117:3379-3389. [PMID: 32667685 DOI: 10.1002/bit.27500] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/02/2020] [Revised: 04/03/2020] [Accepted: 07/13/2020] [Indexed: 11/11/2022]
Abstract
Many manufacturers of biopharmaceuticals are moving from batch to continuous processing. While this approach offers advantages over batch processing, demonstration of viral clearance for continuous processes is challenging. Fluctuating output from a continuous process chromatography column results in a nonhomogeneous load for the subsequent column and must be considered when designing viral clearance studies. One approach to clearance studies is to downscale the connected unit operations and introduce virus by in-line spiking. This is challenging to be implemented at the contract research organization performing the clearance study given the complexity of systems and level of expertise required. Alternately, each unit operation could be evaluated in traditional batch mode but the spiking and loading conditions be modified to mimic the variance introduced by the transition between two connected columns. Using a standard chromatography system, we evaluated a flow-through anion exchange chromatography step in a monoclonal antibody (mAb) manufacturing process using five different methods to introduce the virus to the column. Our data show that whether the virus or the mAbs were introduced in concentrated peaks, or as a homogeneous batch, the clearance of mouse minute virus was similar. This study introduces an alternative way to evaluate viral clearance in a continuous process and demonstrates the robustness of anion exchange chromatography unit operating in continuous processing.
Collapse
Affiliation(s)
- Ying Li
- MilliporeSigma, Process Solutions Bioprocessing, Bedford, Massachusetts
| | - Audrey Chang
- MilliporeSigma, Process Solutions Services, Rockville, Maryland
| | - David Beattie
- MilliporeSigma, Process Solutions Bioprocessing, Bedford, Massachusetts
| | | |
Collapse
|
8
|
Yang B, Wang H, Kaleas K, Butler M, Franklin J, Bill A, Baylis SA, Chen Q, Blümel J. Clearance of porcine circovirus and porcine parvovirus from porcine-derived pepsin by low pH inactivation and cation exchange chromatography. Biotechnol Prog 2020; 36:e2968. [PMID: 31989781 DOI: 10.1002/btpr.2968] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2018] [Revised: 11/22/2019] [Accepted: 12/29/2019] [Indexed: 11/10/2022]
Abstract
The contamination of oral rotavirus vaccines by porcine circovirus (PCV) raised questions about potential PCV contamination of other biological products when porcine trypsin or pepsin is used in production process. Several methods can be potentially implemented as a safety barrier when animal derived trypsin or pepsin is used. Removal of PCV is difficult by the commonly used viral filters with the pore size cutoff of approximately 20 nm because of the smaller size of PCV particles that are around 17 nm. It was speculated that operating the chromatography step at a pH higher than pepsin's low pI, but lower than pIs, of most viruses would allow the pepsin to flow through the resin and be recovered from the flow through pool whilst the viruses would be retained on the resin. In this study, we investigated low pH inactivation of viruses including PCV Type 1 (PCV1) and PCV1 removal by cation exchange chromatography (CEX) in the presence of pepsin. Both parvovirus and PCV1 could be effectively inactivated by low pH and PCV1 could be removed by POROS 50HS CEX. The POROS 50HS method presented in this article is helpful for designing other CEX methods for the same purpose and not much difference would be expected for similar product intermediates and same process parameters. While the effectiveness needs to be confirmed for specific applications, the results demonstrate that both low pH (pH 1.7) and CEX methods were successful in eliminating PCV1 and thus either can be considered as an effective virus barrier.
Collapse
Affiliation(s)
- Bin Yang
- Purification Development, Genentech, Inc., One DNA Way, South San Francisco, California
| | - Hua Wang
- Purification Development, Genentech, Inc., One DNA Way, South San Francisco, California
| | - Kimberly Kaleas
- Purification Development, Genentech, Inc., One DNA Way, South San Francisco, California
| | - Michelle Butler
- Purification Development, Genentech, Inc., One DNA Way, South San Francisco, California
| | - Jayme Franklin
- Purification Development, Genentech, Inc., One DNA Way, South San Francisco, California
| | - Amber Bill
- Purification Development, Genentech, Inc., One DNA Way, South San Francisco, California
| | - Sally A Baylis
- Virus Safety Section, Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, Langen, Germany
| | - Qi Chen
- Purification Development, Genentech, Inc., One DNA Way, South San Francisco, California
| | - Johannes Blümel
- Virus Safety Section, Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, Langen, Germany
| |
Collapse
|
9
|
Polysaccharide-based chromatographic adsorbents for virus purification and viral clearance. J Pharm Anal 2020; 10:291-312. [PMID: 32292625 PMCID: PMC7104128 DOI: 10.1016/j.jpha.2020.01.002] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2019] [Revised: 01/10/2020] [Accepted: 01/11/2020] [Indexed: 12/20/2022] Open
Abstract
Viruses still pose a significant threat to human and animal health worldwide. In the fight against viral infections, high-purity viral stocks are needed for manufacture of safer vaccines. It is also a priority to ensure the viral safety of biopharmaceuticals such as blood products. Chromatography techniques are widely implemented at both academic and industrial levels in the purification of viral particles, whole viruses and virus-like particles to remove viral contaminants from biopharmaceutical products. This paper focuses on polysaccharide adsorbents, particulate resins and membrane adsorbers, used in virus purification/removal chromatography processes. Different chromatographic modes are surveyed, with particular attention to ion exchange and affinity/pseudo-affinity adsorbents among which commercially available agarose-based resins (Sepharose®) and cellulose-based membrane adsorbers (Sartobind®) occupy a dominant position. Mainly built on the development of new ligands coupled to conventional agarose/cellulose matrices, the development perspectives of polysaccharide-based chromatography media in this antiviral area are stressed in the conclusive part. Chromatography has been and is still extensively implemented in virus purification/removal downstream processes. Typical application fields are the manufacturing of purified viral vaccines and virus-free biopharmaceuticals. Agarose and cellulose remain the primary polysaccharide bases for chromatography adsorbents in such virus-related applications. Present R&D studies mainly focus on multimodal chromatography and affinity ligands.
Collapse
|
10
|
Masuda Y, Tsuda M, Hashikawa-Muto C, Takahashi Y, Nonaka K, Wakamatsu K. Cation exchange chromatography performed in overloaded mode is effective in removing viruses during the manufacturing of monoclonal antibodies. Biotechnol Prog 2019; 35:e2858. [PMID: 31148380 DOI: 10.1002/btpr.2858] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2019] [Revised: 04/29/2019] [Accepted: 05/29/2019] [Indexed: 11/07/2022]
Abstract
Viral safety is a critical concern with regard to monoclonal antibody (mAb) products produced in mammalian cells such as Chinese hamster ovary cells. Manufacturers are required to ensure the safety of such products by validating the clearance of viruses in downstream purification steps. Cation exchange (CEX) chromatography is widely used in bind/elute mode as a polishing step in mAb purification. However, bind/elute modes require a large volume of expensive resin. To reduce the production cost, the use of CEX chromatography in overloaded mode has recently been investigated. The viral clearance ability in overloaded mode was evaluated using murine leukemia virus (MLV). Even under high-load conditions such as 2,000 g mAb/L resin, MLV was removed from mAb solutions. This viral clearance ability was not significantly affected by resin type or mAb type. The overloaded mode can also remove other types of viruses such as pseudorabies virus and reovirus Type 3 from mAb solutions. Based on these results, this cost-effective overloaded mode is comparable to the bind-elute mode in terms of viral removal.
Collapse
Affiliation(s)
- Yumiko Masuda
- Biologics Technology Research Laboratories, Daiichi Sankyo Co., Ltd., Ohra-gun, Gunma, Japan.,Graduate School of Science and Technology, Gunma University, Kiryu-shi, Gunma, Japan
| | - Masashi Tsuda
- Biologics Technology Research Laboratories, Daiichi Sankyo Co., Ltd., Ohra-gun, Gunma, Japan
| | - Chie Hashikawa-Muto
- Biologics Technology Research Laboratories, Daiichi Sankyo Co., Ltd., Ohra-gun, Gunma, Japan
| | - Yusuke Takahashi
- Biologics Technology Research Laboratories, Daiichi Sankyo Co., Ltd., Ohra-gun, Gunma, Japan
| | - Koichi Nonaka
- Biologics Technology Research Laboratories, Daiichi Sankyo Co., Ltd., Ohra-gun, Gunma, Japan
| | - Kaori Wakamatsu
- Graduate School of Science and Technology, Gunma University, Kiryu-shi, Gunma, Japan
| |
Collapse
|
11
|
Pan C, Becerra-Arteaga A, Tran B, Chinn M, Wang H, Chen Q, Lutz H, Zhang M. Characterizing and enhancing virus removal by protein A chromatography. Biotechnol Bioeng 2019; 116:846-856. [DOI: 10.1002/bit.26866] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2018] [Revised: 10/29/2018] [Accepted: 11/12/2018] [Indexed: 01/17/2023]
Affiliation(s)
- Chinwei Pan
- Genentech Inc.; South San Francisco California
| | | | | | | | - Hua Wang
- Genentech Inc.; South San Francisco California
| | - Qi Chen
- Genentech Inc.; South San Francisco California
| | - Herb Lutz
- EMD Millipore Corporation; Burlington Massachusetts
| | - Min Zhang
- Genentech Inc.; South San Francisco California
| |
Collapse
|
12
|
Cetlin D, Pallansch M, Fulton C, Vyas E, Shah A, Sohka T, Dhar A, Pallansch L, Strauss D. Use of a noninfectious surrogate to predict minute virus of mice removal during nanofiltration. Biotechnol Prog 2018; 34:1213-1220. [DOI: 10.1002/btpr.2694] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2018] [Revised: 06/08/2018] [Accepted: 07/18/2018] [Indexed: 11/11/2022]
Affiliation(s)
- David Cetlin
- MockV Solutions, Inc. RD 22, Baltimore Road Rockville Maryland, 20850
| | | | - Coral Fulton
- Texcell N.A. 4991 New Design Road Frederick Maryland, 21703
| | - Esha Vyas
- Asahi Kasei America Inc 1855, Elmdale Avenue, Glenview Illinois, 60026
| | - Aesha Shah
- Asahi Kasei America Inc 1855, Elmdale Avenue, Glenview Illinois, 60026
| | - Taka Sohka
- Asahi Kasei America Inc 1855, Elmdale Avenue, Glenview Illinois, 60026
| | - Arun Dhar
- Animal and Comparative Biomedial SciencesAquaculture Pathology Lab University of Arizona 1117 E Lowell Street, VSM Building, Room 201, Tucson Arizona, 85721
| | - Luke Pallansch
- Texcell N.A. 4991 New Design Road Frederick Maryland, 21703
| | - Daniel Strauss
- Asahi Kasei America Inc 1855, Elmdale Avenue, Glenview Illinois, 60026
| |
Collapse
|
13
|
Brown MR, Burnham MS, Lute SC, Johnson SA, Walsh AA, Brorson KA, Roush DJ. Defining the mechanistic binding of viral particles to a multi‐modal anion exchange resin. Biotechnol Prog 2018; 34:1019-1026. [DOI: 10.1002/btpr.2648] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2018] [Revised: 04/24/2018] [Indexed: 12/14/2022]
Affiliation(s)
- Matthew R. Brown
- Food and Drug AdministrationDBRRII, Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and ResearchSilver Spring MD20993
| | | | - Scott C. Lute
- Food and Drug AdministrationDBRRII, Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and ResearchSilver Spring MD20993
| | - Sarah A. Johnson
- Food and Drug AdministrationDBRRII, Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and ResearchSilver Spring MD20993
| | | | - Kurt A. Brorson
- Food and Drug AdministrationDBRRII, Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and ResearchSilver Spring MD20993
| | - David J. Roush
- BioProcess Development, Biologics and VaccinesMerck & Co., Inc.Kenilworth NJ
| |
Collapse
|
14
|
Johnson S, Brorson KA, Frey DD, Dhar AK, Cetlin DA. Characterization of Non-Infectious Virus-Like Particle Surrogates for Viral Clearance Applications. Appl Biochem Biotechnol 2017; 183:318-331. [PMID: 28281181 DOI: 10.1007/s12010-017-2447-y] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2016] [Accepted: 02/20/2017] [Indexed: 10/20/2022]
Abstract
Viral clearance is a critical aspect of biopharmaceutical manufacturing process validation. To determine the viral clearance efficacy of downstream chromatography and filtration steps, live viral "spiking" studies are conducted with model mammalian viruses such as minute virus of mice (MVM). However, due to biosafety considerations, spiking studies are costly and typically conducted in specialized facilities. In this work, we introduce the concept of utilizing a non-infectious MVM virus-like particle (MVM-VLP) as an economical surrogate for live MVM during process development and characterization. Through transmission electron microscopy, size exclusion chromatography with multi-angle light scattering, chromatofocusing, and a novel solute surface hydrophobicity assay, we examined and compared the size, surface charge, and hydrophobic properties of MVM and MVM-VLP. The results revealed that MVM and MVM-VLP exhibited nearly identical physicochemical properties, indicating the potential utility of MVM-VLP as an accurate and economical surrogate to live MVM during chromatography and filtration process development and characterization studies.
Collapse
Affiliation(s)
- Sarah Johnson
- DBRRII, Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, 20993, USA
| | - Kurt A Brorson
- DBRRII, Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, 20993, USA
| | - Douglas D Frey
- Department of Chemical, Biochemical, and Environmental Engineering, University of Maryland Baltimore County, Baltimore, MD, 21250, USA
| | - Arun K Dhar
- MockV Solutions, Inc., 22 Baltimore Road, Rockville, MD, 20850, USA
| | - David A Cetlin
- MockV Solutions, Inc., 22 Baltimore Road, Rockville, MD, 20850, USA.
| |
Collapse
|
15
|
Conley L, Tao Y, Henry A, Koepf E, Cecchini D, Pieracci J, Ghose S. Evaluation of eco-friendly zwitterionic detergents for enveloped virus inactivation. Biotechnol Bioeng 2016; 114:813-820. [PMID: 27800626 DOI: 10.1002/bit.26209] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2016] [Revised: 09/27/2016] [Accepted: 10/28/2016] [Indexed: 01/29/2023]
Abstract
Inclusion of a detergent in protein biotherapeutic purification processes is a simple and very robust method for inactivating enveloped viruses. The detergent Triton X-100 has been used for many years and is part of the production process of several commercial therapeutic proteins. However, recent ecological studies have suggested that Triton X-100 and its break-down products can potentially behave as endocrine disrupters in aquatic organisms, raising concerns from an environmental impact perspective. As such, discharge of Triton X-100 into the waste water treatment plants is regulated in some jurisdictions, and alternative detergents for viral inactivation are required. In this work, we report on the identification and evaluation of more eco-friendly detergents as viable replacements for Triton X-100. Five detergent candidates with low to moderate environmental impact were initially identified and evaluated with respect to protein stability, followed by proof-of-concept virus inactivation studies using a model enveloped virus. From the set of candidates lauryldimethylamine N-oxide (LDAO) was identified as the most promising detergent due to its low ecotoxicity, robust anti-viral activity (LRV >4 at validation set-point conditions with X-MuLX), and absence of any negative impact on protein function. This detergent exhibited effective and robust virus inactivation in a broad range of protein concentrations, solution conductivities, pHs, and in several different cell culture fluid matrices. The only process parameter which correlated with reduced virus inactivation potency was LDAO concentration, and then only when the concentration was reduced to below the detergent's critical micelle concentration (CMC). Additionally, this work also demonstrated that LDAO was cleared to below detectable levels after Protein A affinity chromatography, making it suitable for use in a platform process that utilizes this chromatographic mode for protein capture. All these findings suggest that LDAO may be a practical alternative to Triton X-100 for use in protein therapeutic production processes for inactivating enveloped viruses. Biotechnol. Bioeng. 2017;114: 813-820. © 2016 Wiley Periodicals, Inc.
Collapse
Affiliation(s)
- Lynn Conley
- Process Biochemistry, Biogen, 5000 Davis Drive, Research Triangle Park 27709, North Carolina
| | - Yinying Tao
- Bioproduct Research and Development, Eli Lilly and Company, Indianapolis, Indiana
| | - Alexis Henry
- Process Biochemistry, Biogen, 5000 Davis Drive, Research Triangle Park 27709, North Carolina
| | - Edward Koepf
- Process Biochemistry, Biogen, 5000 Davis Drive, Research Triangle Park 27709, North Carolina
| | | | - John Pieracci
- Process Biochemistry, Biogen, Cambridge, Massachusetts
| | - Sanchayita Ghose
- Process Biochemistry, Biogen, 5000 Davis Drive, Research Triangle Park 27709, North Carolina
| |
Collapse
|
16
|
Liu Z, Wickramasinghe SR, Qian X. Membrane chromatography for protein purifications from ligand design to functionalization. SEP SCI TECHNOL 2016. [DOI: 10.1080/01496395.2016.1223133] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Affiliation(s)
- Zizhao Liu
- Department of Chemical Engineering, University of Arkansas, Fayetteville, Arkansas, USA
| | | | - Xianghong Qian
- Department of Biomedical Engineering, University of Arkansas, Fayetteville, Arkansas, USA
| |
Collapse
|
17
|
Bolton GR, Mehta KK. The role of more than 40 years of improvement in protein A chromatography in the growth of the therapeutic antibody industry. Biotechnol Prog 2016; 32:1193-1202. [DOI: 10.1002/btpr.2324] [Citation(s) in RCA: 71] [Impact Index Per Article: 8.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2016] [Revised: 07/03/2016] [Indexed: 01/05/2023]
|
18
|
Steinebach F, Müller-Späth T, Morbidelli M. Continuous counter-current chromatography for capture and polishing steps in biopharmaceutical production. Biotechnol J 2016; 11:1126-41. [PMID: 27376629 DOI: 10.1002/biot.201500354] [Citation(s) in RCA: 69] [Impact Index Per Article: 8.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2015] [Revised: 12/21/2015] [Accepted: 05/30/2016] [Indexed: 12/11/2022]
Abstract
The economic advantages of continuous processing of biopharmaceuticals, which include smaller equipment and faster, efficient processes, have increased interest in this technology over the past decade. Continuous processes can also improve quality assurance and enable greater controllability, consistent with the quality initiatives of the FDA. Here, we discuss different continuous multi-column chromatography processes. Differences in the capture and polishing steps result in two different types of continuous processes that employ counter-current column movement. Continuous-capture processes are associated with increased productivity per cycle and decreased buffer consumption, whereas the typical purity-yield trade-off of classical batch chromatography can be surmounted by continuous processes for polishing applications. In the context of continuous manufacturing, different but complementary chromatographic columns or devices are typically combined to improve overall process performance and avoid unnecessary product storage. In the following, these various processes, their performances compared with batch processing and resulting product quality are discussed based on a review of the literature. Based on various examples of applications, primarily monoclonal antibody production processes, conclusions are drawn about the future of these continuous-manufacturing technologies.
Collapse
Affiliation(s)
- Fabian Steinebach
- Institute for Chemical and Bioengineering, Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland
| | | | - Massimo Morbidelli
- Institute for Chemical and Bioengineering, Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland.
| |
Collapse
|
19
|
Nian R, Gagnon P. Advance chromatin extraction enhances performance and productivity of cation exchange chromatography-based capture of Immunoglobulin G monoclonal antibodies. J Chromatogr A 2016; 1453:54-61. [DOI: 10.1016/j.chroma.2016.05.029] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2015] [Revised: 04/03/2016] [Accepted: 05/06/2016] [Indexed: 12/28/2022]
|
20
|
Levy NE, Valente KN, Lee KH, Lenhoff AM. Host cell protein impurities in chromatographic polishing steps for monoclonal antibody purification. Biotechnol Bioeng 2015; 113:1260-72. [DOI: 10.1002/bit.25882] [Citation(s) in RCA: 55] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2015] [Revised: 10/19/2015] [Accepted: 11/05/2015] [Indexed: 12/24/2022]
Affiliation(s)
- Nicholas E. Levy
- Department of Chemical and Biomolecular EngineeringUniversity of DelawareNewarkDelaware19716
| | - Kristin N. Valente
- Department of Chemical and Biomolecular EngineeringUniversity of DelawareNewarkDelaware19716
- Delaware Biotechnology InstituteNewarkDelaware19711
| | - Kelvin H. Lee
- Department of Chemical and Biomolecular EngineeringUniversity of DelawareNewarkDelaware19716
- Delaware Biotechnology InstituteNewarkDelaware19711
| | - Abraham M. Lenhoff
- Department of Chemical and Biomolecular EngineeringUniversity of DelawareNewarkDelaware19716
| |
Collapse
|
21
|
Hammerschmidt N, Hintersteiner B, Lingg N, Jungbauer A. Continuous precipitation of IgG from CHO cell culture supernatant in a tubular reactor. Biotechnol J 2015; 10:1196-205. [DOI: 10.1002/biot.201400608] [Citation(s) in RCA: 46] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2014] [Revised: 11/27/2014] [Accepted: 12/23/2014] [Indexed: 11/09/2022]
|
22
|
Chai DS, Sun Y, Wang XN, Shi QH. Improved purification of immunoglobulin G from plasma by mixed-mode chromatography. J Sep Sci 2014; 37:3461-72. [DOI: 10.1002/jssc.201400554] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2014] [Revised: 09/03/2014] [Accepted: 09/08/2014] [Indexed: 11/11/2022]
Affiliation(s)
- Dong-Sheng Chai
- Department of Biochemical Engineering; Key Laboratory of Systems Bioengineering; School of Chemical Engineering and Technology; Tianjin University; Tianjin China
| | - Yan Sun
- Department of Biochemical Engineering; Key Laboratory of Systems Bioengineering; School of Chemical Engineering and Technology; Tianjin University; Tianjin China
- Collaborative Innovation Centre of Chemical Science and Engineering; Tianjin China
| | - Xiao-Ning Wang
- Vaccines Research Department 3; Beijing Tiantan Biological Products Co. Ltd; Beijing China
| | - Qing-Hong Shi
- Department of Biochemical Engineering; Key Laboratory of Systems Bioengineering; School of Chemical Engineering and Technology; Tianjin University; Tianjin China
- Collaborative Innovation Centre of Chemical Science and Engineering; Tianjin China
| |
Collapse
|
23
|
Kaleas KA, Tripodi M, Revelli S, Sharma V, Pizarro SA. Evaluation of a multimodal resin for selective capture of CHO-derived monoclonal antibodies directly from harvested cell culture fluid. J Chromatogr B Analyt Technol Biomed Life Sci 2014; 969:256-63. [DOI: 10.1016/j.jchromb.2014.08.026] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2014] [Revised: 08/17/2014] [Accepted: 08/22/2014] [Indexed: 10/24/2022]
|
24
|
Ji Y, Tian Y, Ahnfelt M, Sui L. Design and optimization of a chromatographic purification process for Streptococcus pneumoniae serotype 23F capsular polysaccharide by a Design of Experiments approach. J Chromatogr A 2014; 1348:137-49. [PMID: 24845825 DOI: 10.1016/j.chroma.2014.04.096] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2014] [Revised: 04/13/2014] [Accepted: 04/29/2014] [Indexed: 11/28/2022]
Abstract
Multivalent pneumococcal vaccines were used worldwide to protect human beings from pneumococcal diseases. In order to eliminate the toxic organic solutions used in the traditional vaccine purification process, an alternative chromatographic process for Streptococcus pneumoniae serotype 23F capsular polysaccharide (CPS) was proposed in this study. The strategy of Design of Experiments (DoE) was introduced into the process development to solve the complicated design procedure. An initial process analysis was given to review the whole flowchart, identify the critical factors of chromatography through FMEA and chose the flowthrough mode due to the property of the feed. A resin screening study was then followed to select candidate resins. DoE was utilized to generate a resolution IV fractional factorial design to further compare candidates and narrow down the design space. After Capto Adhere was selected, the Box-Behnken DoE was executed to model the process and characterize all effects of factors on the responses. Finally, Monte Carlo simulation was used to optimize the process, test the chosen optimal conditions and define the control limit. The results of three scale-up runs at set points verified the DoE and simulation predictions. The final results were well in accordance with the EU pharmacopeia requirements: Protein/CPS (w/w) 1.08%; DNA/CPS (w/w) 0.61%; the phosphorus content 3.1%; the nitrogen 0.315% and the Methyl-pentose percentage 47.9%. Other tests of final pure CPS also met the pharmacopeia specifications. This alternative chromatographic purification process for pneumococcal vaccine without toxic organic solvents was successfully developed by the DoE approach and proved scalability, robustness and suitability for large scale manufacturing.
Collapse
Affiliation(s)
- Yu Ji
- GE Healthcare Fast Trak China, 1800 Cailun Road, Zhangjiang Hi-tech Park, Pudong, Shanghai 201203, China.
| | - Yang Tian
- GE Healthcare Fast Trak China, 1800 Cailun Road, Zhangjiang Hi-tech Park, Pudong, Shanghai 201203, China
| | - Mattias Ahnfelt
- GE Healthcare Bio-Sciences, Björkgatan 30, SE-75184 Uppsala, Sweden
| | - Lili Sui
- GE Healthcare Fast Trak China, 1800 Cailun Road, Zhangjiang Hi-tech Park, Pudong, Shanghai 201203, China
| |
Collapse
|
25
|
Miesegaes GR, Lute SC, Read EK, Brorson KA. Viral clearance by flow-through mode ion exchange columns and membrane adsorbers. Biotechnol Prog 2013; 30:124-31. [DOI: 10.1002/btpr.1832] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2013] [Revised: 10/15/2013] [Indexed: 11/08/2022]
Affiliation(s)
- G. R. Miesegaes
- Office of Biotechnology Products,CDER/FDA; 10903 New Hampshire Ave. Silver Spring MD 20903
| | - S. C. Lute
- Office of Biotechnology Products,CDER/FDA; 10903 New Hampshire Ave. Silver Spring MD 20903
| | - E. K. Read
- Office of Biotechnology Products,CDER/FDA; 10903 New Hampshire Ave. Silver Spring MD 20903
| | - K. A. Brorson
- Office of Biotechnology Products,CDER/FDA; 10903 New Hampshire Ave. Silver Spring MD 20903
| |
Collapse
|
26
|
Bolton GR, Ackerman ME, Boesch AW. Separation of nonfucosylated antibodies with immobilized FcγRIII receptors. Biotechnol Prog 2013; 29:825-8. [PMID: 23554380 DOI: 10.1002/btpr.1717] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2012] [Revised: 02/22/2013] [Accepted: 02/22/2013] [Indexed: 11/11/2022]
Abstract
Post-translational modifications can dramatically impact protein activity, but identifying such structure:function relationships, as well as capitalizing on functionally enhanced variants, is a significant challenge. Here, affinity chromatography resins that contained immobilized FcγRIII receptors were used to enrich nonfucosylated antibodies 6- to 9-fold, offering what may be a tractable method for both the identification of post-translational modifications that affect function, as well as a means to enrich variants with enhanced activity.
Collapse
Affiliation(s)
- Glen R Bolton
- Process Biochemistry, Biogen Idec, Cambridge, MA, 02142, USA
| | | | | |
Collapse
|